About Matt Beaudet
Matt Beaudet is president and chief executive officer of Araceli Biosciences, which makes high-content imaging and AI analysis systems for drug discovery labs. He is also a board member there.
Before Araceli, Beaudet was co-founder and chief executive officer of InVivo Biosystems. He earlier held leadership roles at Molecular Probes, Invitrogen, and Life Technologies, over more than twenty years in the biotech industry.
Experience
This experience comes from official bios and from SEC filings. For roles taken from filings, the years are when the filings name Matt Beaudet in the role, so the role may have started earlier or lasted longer.
Araceli Biosciences Inc. Current
President and CEO, director
2024 – Present · Tigard, OR
Araceli Biosciences makes high-content imaging and AI analysis systems that help drug discovery labs screen compounds faster.
IB
InVivo Biosystems
Co-Founder and CEO
Key Colleagues at Startups
The people Matt Beaudet works with at each company, as listed on that company's latest Form D.
Araceli Biosciences Inc. · Form D, Nov 3, 2026
WC
William Cortelyou
Chairman of the Board
J. William Freytag
Director
Kirk Malloy
Director
Sean O'Neill
Director
SR
Samraat Raha
Director
Bruce Rhine
Director
Christine Ann Tsingos
Director